Rimsev 400 Tablet
Rimsev 400: Advanced Phosphate Management for Dialysis Patients
Rimsev 400 Tablet, containing Sevelamer Carbonate, is a specialized prescription medication designed to effectively manage elevated phosphate levels in the blood (hyperphosphatemia). It is a critical treatment for patients undergoing dialysis due to severe chronic kidney disease (CKD). As a potent phosphate binder, Rimsev 400 works by inhibiting the absorption of dietary phosphate from the intestine, thereby lowering blood phosphate levels and helping to prevent complications such as hypocalcemia (low calcium levels) often triggered by high phosphorus.
How Rimsev 400 Works: When taken with meals, Sevelamer Carbonate binds to phosphate in the digestive tract, forming an insoluble complex that is then excreted from the body. This mechanism prevents phosphate from being absorbed into the bloodstream, helping to maintain a healthy balance of minerals in patients with impaired kidney function.
Key Benefits of Rimsev 400 Tablet:
- Effective Phosphate Binding with No Absorption: Ensures powerful binding of dietary phosphate within the gut, with the active ingredient itself not being absorbed into the bloodstream, minimizing systemic side effects.
- Improves Serum Bicarbonate Levels: Helps to stabilize serum bicarbonate levels, playing a vital role in preventing and managing metabolic acidosis, a common complication in CKD patients.
- Reduces Vascular Calcification Risk: Significantly lowers the chances of vascular calcification and coronary artery calcification, crucial for protecting cardiovascular health in CKD patients.
- Comprehensive Biomarker Reduction: Beyond phosphate, it significantly reduces levels of serum cholesterol, uric acid, FGF23 (Fibroblast Growth Factor 23), and HbA1c (Glycated Hemoglobin), offering broad metabolic benefits.
- High Responder Rate in Indian Patients: Demonstrates a high responder rate of more than 70% in Indian patients, indicating its proven efficacy and suitability for the local demographic.
Rimsev 400 Tablet from Evervital Lifesciences provides advanced and multifaceted support for patients on dialysis, offering effective phosphate control and contributing to improved overall health outcomes in chronic kidney disease.
- Description
Description
Rimsev 400: Advanced Phosphate Management for Dialysis Patients
Rimsev 400 Tablet, containing Sevelamer Carbonate, is a specialized prescription medication designed to effectively manage elevated phosphate levels in the blood (hyperphosphatemia). It is a critical treatment for patients undergoing dialysis due to severe chronic kidney disease (CKD). As a potent phosphate binder, Rimsev 400 works by inhibiting the absorption of dietary phosphate from the intestine, thereby lowering blood phosphate levels and helping to prevent complications such as hypocalcemia (low calcium levels) often triggered by high phosphorus.
How Rimsev 400 Works: When taken with meals, Sevelamer Carbonate binds to phosphate in the digestive tract, forming an insoluble complex that is then excreted from the body. This mechanism prevents phosphate from being absorbed into the bloodstream, helping to maintain a healthy balance of minerals in patients with impaired kidney function.
Key Benefits of Rimsev 400 Tablet:
- Effective Phosphate Binding with No Absorption: Ensures powerful binding of dietary phosphate within the gut, with the active ingredient itself not being absorbed into the bloodstream, minimizing systemic side effects.
- Improves Serum Bicarbonate Levels: Helps to stabilize serum bicarbonate levels, playing a vital role in preventing and managing metabolic acidosis, a common complication in CKD patients.
- Reduces Vascular Calcification Risk: Significantly lowers the chances of vascular calcification and coronary artery calcification, crucial for protecting cardiovascular health in CKD patients.
- Comprehensive Biomarker Reduction: Beyond phosphate, it significantly reduces levels of serum cholesterol, uric acid, FGF23 (Fibroblast Growth Factor 23), and HbA1c (Glycated Hemoglobin), offering broad metabolic benefits.
- High Responder Rate in Indian Patients: Demonstrates a high responder rate of more than 70% in Indian patients, indicating its proven efficacy and suitability for the local demographic.
Rimsev 400 Tablet from Evervital Lifesciences provides advanced and multifaceted support for patients on dialysis, offering effective phosphate control and contributing to improved overall health outcomes in chronic kidney disease.
